Log in to save to my catalogue

Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0aa2077077d243cb9f117c28a0c8e4f1

Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

About this item

Full title

Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2020-08, Vol.11 (1), p.3946-3946, Article 3946

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Melanomas can switch to a dedifferentiated cell state upon exposure to cytotoxic T cells. However, it is unclear whether such tumor cells pre-exist in patients and whether they can be resensitized to immunotherapy. Here, we chronically expose (patient-derived) melanoma cell lines to differentiation antigen-specific cytotoxic T cells and observe str...

Alternative Titles

Full title

Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0aa2077077d243cb9f117c28a0c8e4f1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0aa2077077d243cb9f117c28a0c8e4f1

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-020-17739-8

How to access this item